Jiangsu Hengrui Pharma A/H Listing - Low-End Is Probably Close to Fair Value
Jiangsu Hengrui Medicine (600276 CH), a China-based pharmaceutical company, aims to raise around US$1.3bn in its H-share listing. In this note, we...
634 Views
ECM Weekly (12 May 2025) - CATL, Hengrui, Ather, Drinda, Green Tea, Swiggy, Sagility, Niva Bupa
Aequitas Research's weekly update on the IPOs, placements, lockup expiry and other ECM linked events that were covered by the team over the past week.
524 Views
SHEIN Vs Amazon, Part II: What Changed Since Our Last Shopping Adventure? SHEIN Cost Nearly Tripled!
Our personal shopping "experiment" suggests that SHEIN has lost most of the price advantage it enjoyed over US eComm giant Amazon a year and a half...
641 Views
[Blue Lotus Daily-TMT Update]:BIDU US/JD US/PDD US/AAPL US/BILI US/700 HK
Baidu partners with CAR Inc for autonomous ride-hailing, JD.com launches tech talent program, Pinduoduo sees slight increase in service fees.
378 Views
CX Daily: China Unveils Monetary Support to Stem U.S. Tariff Impact
TOP STORIES Autos / In Depth: U. S. tariffs rattle global auto industry At an October campaign rally in Michigan, then-presidential candidate...
240 Views